XML 21 R3.htm IDEA: XBRL DOCUMENT v3.22.4
CONSOLIDATED STATEMENTS OF INCOME (LOSS) - USD ($)
shares in Millions, $ in Millions
12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Dec. 31, 2020
Income Statement [Abstract]      
Revenues $ 2,704.7 $ 2,646.9 $ 2,675.5
Cost of revenues 1,679.1 1,629.7 1,622.4
Gross profit 1,025.6 1,017.2 1,053.1
Selling, general and administrative expenses 887.5 946.6 897.6
Divestiture (gains) losses, net (15.6) (1.7) 123.6
Income from operations 153.7 72.3 31.9
Interest (expense) income, net (75.5) (71.9) (81.9)
Other income (expense), net 0.7 0.3 (6.0)
Income (loss) before income taxes 78.9 0.7 (56.0)
Income tax (expense) benefit (22.4) (27.5) 0.1
Net income (loss) 56.5 (26.8) (55.9)
Net income attributable to noncontrolling interests (0.5) (1.0) (1.4)
Net income (loss) attributable to Stericycle, Inc. common shareholders $ 56.0 $ (27.8) $ (57.3)
Earnings (loss) per common share attributable to Stericycle, Inc. common shareholders:      
Basic (in dollars per share) $ 0.61 $ (0.30) $ (0.63)
Diluted (in dollars per share) $ 0.61 $ (0.30) $ (0.63)
Weighted average number of common shares Outstanding:      
Basic (in shares) 92.1 91.8 91.5
Diluted (in shares) 92.4 91.8 91.5